ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel

June 4, 1999

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981

Chemotherapy After Surgery Extends Survival By 32%

January 27, 2006

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

June 23, 1978